4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-24-000122
Director sold 1,674 shares at $20.39 ($34,133)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SATO VICKI L Director | 2024-05-15 | Sale 10b5-1 | −1,674 | $20.39 | $34,133 | 116,369 | D: show line 1 in the form |
| Open-market sales · 1,674 sh · avg $20.39 · $34,133 | |||||||
Loading xslF345X05/wk-form4_1715977693.xml…